External PhD candidate Erasmus School of Health Policy & Management Health Technology Assessment (HTA)
- Location
- Burg. Oudlaan 50, Rotterdam
- l.a.visser@eshpm.eur.nl
‹ Back to overview
Profile
- Laurenske Visser (2021) - The potential of a novel cell-based therapy delivery implant in multiple sclerosis: n early health technology assessment
- Juliette de Vos, Laurenske A. Visser, Aletta A. de Beer, Mattia Fornasa, Patrick J. Thoral, Paul W.G. Elbers & Giovanni Cinà (2021) - The Potential Cost-Effectiveness of a Machine Learning Tool That Can Prevent Untimely Intensive Care Unit Discharge - Value in Health, 25 (3), 359-367 - doi: 10.1016/j.jval.2021.06.018 - [link]
- Laurenske A. Visser, Marc Folcher, Claudia Delgado Simao, Biotza Gutierrez Arechederra, Encarna Escudero, Carin A. Uyl-de Groot & William Ken Redekop (2021) - The Potential Cost-Effectiveness of a Cell-Based Bioelectronic Implantable Device Delivering Interferon-β1a Therapy Versus Injectable Interferon-β1a Treatment in Relapsing–Remitting Multiple Sclerosis - PharmacoEconomics, 40 (1), 91-108 - doi: 10.1007/s40273-021-01081-y - [link]
- Laurenske Visser, Marleen de Mul & Ken Redekop (2021) - Innovative Medical Technology and the Treatment Decision-Making Process in Multiple Sclerosis:: A Focus Group Study to Examine Patient Perspectives - Patient Preference and Adherence, 15, 927-937 - doi: 10.2147/PPA.S306132 - [link]
- Laurenske A. Visser, Celine Louapre, Carin A. Uyl-de Groot & WK (Ken) Redekop (2021) - Health-related quality of life of multiple sclerosis patients: a European multi-country study - Archives of Public Health, 79 (1) - doi: 10.1186/s13690-021-00561-z - [link]
- Laurenske Visser, C Louapre, Carin Uyl - de Groot & Ken Redekop (2020) - Patient needs and preferences in relapsing-remitting multiple sclerosis: A systematic review - Multiple Sclerosis and Related Disorders, 39, 101929 - doi: 10.1016/j.msard.2020.101929
Integration project
- Level
- bachelor 1
- Year
- 2021
- Year Level
- bachelor 1
- Course Code
- GW104I
